| 11 |
Health economics: direct cost of osteoporotic hip fracture in Egypt—an analysis for the Egyptian healthcare system by the Egyptian Academy of Bone Health |
2023 |
| 12 |
Incidence and geographic characteristics of the population with osteoporotic hip fracture in Egypt—by the Egyptian Academy of Bone Health |
2023 |
| 13 |
One musculoskeletal health: towards optimizing musculoskeletal health in Egypt—how to be a bone and muscle builder by the Egyptian Academy of Bone Health and Metabolic Bone Diseases |
2023 |
| 14 |
Osteoporosis treatment gap in patients at risk of fracture in Egypt: a multi-center, cross-sectional observational study |
2023 |
| 15 |
Sarcopenia in Egypt: epidemiology of sarcopenia risk among older adults presenting with fragility fractures—an initiative by the Egyptian Academy of Bone Health |
2023 |
| 16 |
Serum and synovial fluid 14-3-3η protein in patients with primary knee osteoarthritis compared with rheumatoid arthritis: relation to functional status and radiographic damage |
2023 |
| 17 |
Standards for structured reporting of dual-energy X-ray absorptiometry scans: best practice recommendations by the Pan Arab Osteoporosis Society |
2023 |
| 18 |
Targeted optimum care approach for osteoporotic fragility fractures: tailored strategy based on risk stratification to reduce incidents of falls—an initiative by the Egyptian Academy of bone health based on the FLS national register |
2023 |
| 19 |
Circulating microparticles and activated platelets as novel prognostic biomarkers in COVID-19; relation to cancer |
2021 |
| 20 |
Clinical impact of the ABO blood type in patients with rheumatic diseases: is there a link to the ABO and rhesus? |
2021 |
هل لديك سؤال ؟
